An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

The benefits and challenges of returning to academia after a period away ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...

Q3 2025 Earnings Call October 30, 2025 8:30 AM EDTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor ...

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet ...

BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the company's PALYNZIQ® (pegvaliase-pqpz) supplemental Biologics License ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the ...